allulose glp 1 agonist GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose Secretion of GLP-1 but not

Then, we will discuss the approaches that can increase the endogenous production of GLP-1 through various stimuli

Introduction Diabetes is a chronic disease that occurs when the pancreas does not produce ade

How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors

Discover how GLP-1 drugs like semaglutide & tirzepatide are transforming obesity care with weight loss results rivaling bariatric surgery.

This review delves into the physiological roles of GLP-1, exploring its impact on ...

Research shows that nearly 90% of people with type 2 diabetes also struggle with their weight, and these medications solve both problems at once